Table 2. Evaluation of macular and choroidal thickness in control group and study group.
Variables | Healthy women (control group) (n=72) | Pregnant women (study group) (n=58) | After pregnancy (study group) (n=58) |
P |
||
Healthy women vs pregnant womena | Healthy women vs after pregnancya | Pregnant women vs after pregnancyb | ||||
SFCT | 320.86±59.18 | 387.97±59.91 | 332.40±26.03 | 0.000 | 0.170 | 0.000 |
Fovealc | 257.24±17.88 | 255.03±17.87 | 252.47±21.37 | 0.486 | 0.168 | 0.363 |
Superior quadrantd | 343.67±13.41 | 342.78±11.37 | 343.40±13.02 | 0.688 | 0.908 | 0.751 |
Temporal quadrantd | 335.26±13.07 | 332.57±14.71 | 336.47±16.70 | 0.271 | 0.646 | 0.094 |
Inferior quadrantd | 337.51±13.82 | 337.10±12.13 | 338.57±12.64 | 0.859 | 0.654 | 0.379 |
Nasal quadrantd | 333.32±14.84 | 331.79±15.11 | 329.90±14.04 | 0.564 | 0.183 | 0.456 |
SFCT: Subfoveal choroidal thickness. aİndependent Student's t-test; bPaired t-test; cMacular thickness in 1 mm field; dMacular thickness in 3 mm field